Anti-Obesity Drug Discovery and Development

Volume 3

by

Prof. Dr. Atta-ur-Rahman, Prof. Dr. M. Iqbal Choudhary

DOI: 10.2174/97816810818781170301
eISBN: 978-1-68108-187-8, 2017
ISBN: 978-1-68108-188-5
ISSN: 2467-9615 (Print)
ISSN: 2210-2698 (Online)



Indexed in: Ulrich's Periodicals Directory.

Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic p...[view complete introduction]
US $
Buy Personal eBook
79
Order Library eBook
316
Order Printed Copy
*95
Order PDF + Printed Copy (Special Offer)
*134

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology

Unravelling Potential Anorexigen Effects of Nesfatin-1: How Homeostatic Mechanisms Help Balance Excess Calories

- Pp. 65-79 (15)

Carmine Finelli

Abstract

In this chapter, we review the current concepts about Nesfatin-1 as a new anti-obesity treatment and evaluate the existing issues about this knowledge and the available literature. The intent is to inform clinicians about Nesfatin-1 as a new kind of anti-obesity treatment and make a rational decision based on this perspective as possible clinical application. It can be potentially helpful in the therapy of metabolic disorders and obesity of various origins. In fact, the details of nesfatin-1 physiology could be clarified, and it may be considered suitable in the future as a potential drug in the pharmacotherapy of obesity, due to its anorexigenic effects, and as a new potential modulator of appetite in the therapy of eating disorders such as anorexia nervosa by using selective nesfatin-1 antagonists. Therefore, further progress of pharmacological researches in this field is still very limited. Further research on this topic certainly merit attention.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science